熱門資訊> 正文

Viatris获得Gwyn Lo避孕贴批准

2026-07-29 22:57

The US FDA has approved Viatris' (VTRS) Gwyn Lo (norelgestromin and ethinyl estradiol transdermal system) contraceptive patch.
Gwyn Lo is applied weekly for three consecutive weeks, and then one patch-free week.
Approval was based on the results from the phase 3 Luminous study.
The patch will become available later this year.

More on Viatris

Viatris Soared 54%: Time To Be More Careful (Rating Downgrade)
Viatris Inc. (VTRS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Viatris: From Cost Story To Pipeline-Driven Re-Rating (Rating Upgrade)
Merck signs licensing deals with companies including Viatris for new HIV pill
Viatris reports positive Japanese phase 3 results for Nefecon in IgAN

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。